GlassScriptPhysician profile
Fadi Michael Tamer
NPI 1174599633
$2,216.26
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $976 · 2020: $471 · 2021: $770.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $385.34 | 2019-2021 | |
| Amgen INC. | $333.09 | 2019-2020 | |
| Pfizer INC. | $228.69 | 2019-2021 | |
| Amarin Pharma, INC. | $213.86 | 2019-2021 | |
| Lilly USA, LLC | $201.43 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $137.69 | 2020-2021 | |
| Abbvie INC. | $129.83 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.97 | 2019-2021 | |
| Eisai INC. | $71.21 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $71.14 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.49 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $56.07 | 2019-2021 | |
| Glaxosmithkline, LLC. | $42.23 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $40.69 | 2021 | |
| Currax Pharmaceuticals LLC | $26.68 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $21.37 | 2021 | |
| Biogen, INC. | $19.09 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.65 | 2021 | |
| Organogenesis INC. | $14.89 | 2021 | |
| Boston Scientific Corporation | $12.97 | 2019 | |
| Zyla Life Sciences, INC. | $12.21 | 2020 | |
| Esperion Therapeutics, INC. | $11.67 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Tamer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.